US Map / Washington D.C.
State DC

Clinical Trials in Washington D.C.

Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.

Total Trials
145
Recruiting Now
145
← Back to US Map
Top Conditions in Washington D.C.
Breast Cancer (6)Head and Neck Squamous Cell Carcinoma (3)Esophageal Cancer (3)Prostate Cancer (3)Prostate Adenocarcinoma (3)Chronic Inflammatory Demyelinating Polyneuropathy (2)Bladder Cancer (2)Multiple Sclerosis (2)Stage IV Lung Cancer AJCC v8 (2)High Grade Glioma (2)Diffuse Intrinsic Pontine Glioma (2)Asthma (2)

Frequently Asked Questions — Clinical Trials in Washington D.C.

How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 145 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 145. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Head and Neck Squamous Cell Carcinoma, Esophageal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Washington D.C.

NCT04786977 N/A
Recruiting
Physiologic Measure of VIPN
Condition
Chemotherapy-induced Peripheral Neuropathy
Enrollment
40 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT06739122 Phase 3
Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants W...
Condition
Type 2 Diabetes
Enrollment
55 pts
Location
United States, Argentina, Mexico
Sponsor
Eli Lilly and Company
View Trial →
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,600 pts
Location
United States, Austria, France
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06662942 Phase 1
Recruiting
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
Condition
Vulvar Lichen Sclerosus
Enrollment
100 pts
Location
United States
Sponsor
Andrew T. Goldstein, MD
View Trial →
NCT06534983 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab...
Condition
Muscle-invasive Urothelial Carcinoma
Enrollment
362 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT06872892 Phase 3
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...
Condition
Bronchiectasis
Enrollment
1,755 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06822426 Phase 3
Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodst...
Condition
Central Line Associated Blood Stream Infections (CLABSI)
Enrollment
200 pts
Location
United States
Sponsor
CorMedix
View Trial →
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
View Trial →
NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (...
Condition
Breast Cancer
Enrollment
750 pts
Location
United States, France, Germany
Sponsor
Greenwich LifeSciences, Inc.
View Trial →
NCT06248515 Phase 2
Recruiting
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epith...
Condition
Thymoma
Enrollment
18 pts
Location
United States
Sponsor
Georgetown University
View Trial →
NCT06814717 Phase 2
Recruiting
A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10...
Condition
Thermal Burns
Enrollment
6 pts
Location
United States
Sponsor
Neomatrix Therapeutics, Inc.
View Trial →
NCT03604835 N/A
Recruiting
Mucopolysaccharidosis VII Disease Monitoring Program
Condition
Mucopolysaccharidosis VII
Enrollment
50 pts
Location
United States, Argentina, Brazil
Sponsor
Ultragenyx Pharmaceutical Inc
View Trial →
NCT04841148 Phase 2
Recruiting
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant ...
Condition
Breast Cancer
Enrollment
96 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →
NCT06941025 N/A
Recruiting
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Ass...
Condition
Fabry Disease
Enrollment
10 pts
Location
United States, Germany, Italy
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
NCT01999140 N/A
Recruiting
Implantable Cardioverter Defibrillator (ICD Registry)
Condition
Heart Failure
Enrollment
1,750 pts
Location
United States
Sponsor
American College of Cardiology
View Trial →
NCT06224933 N/A
Recruiting
Augmented Reality For MRI-Guided Interventions
Condition
Infections
Enrollment
25 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT06122090 Phase 2
Recruiting
Treatment of Hypopigmented Scars With Bimatoprost
Condition
Scars
Enrollment
25 pts
Location
United States
Sponsor
Medstar Health Research Instit
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06193759 Phase 1
Recruiting
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular T...
Condition
Medulloblastoma, Childhood
Enrollment
12 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT03028246 N/A
Recruiting
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pe...
Condition
Benign Centrally-Located Intracranial Tumors
Enrollment
20 pts
Location
United States
Sponsor
InSightec
View Trial →
NCT06777368 N/A
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failu...
Condition
Aortic Stenosis
Enrollment
225 pts
Location
United States
Sponsor
Medtronic Cardiovascular
View Trial →
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
Page 4 of 6 — 145 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology